Market Access/ News/ News/ Pharma Market Access/ R&D/ Top stories China to accept overseas clinical trial data Richard Staines AstraZeneca, Boehringer Ingelheim, CFDA, Novo Nordisk, R&D, regulation 0 Comment The Chinese government has announced plans to accept data from clinical trials carried out overseas, in order to Share X China to accept overseas clinical trial data https://pharmaphorum.com/news/china-accept-overseas-clinical-trial-data/
AstraZeneca, Boehringer Ingelheim, CFDA, Novo Nordisk, R&D, regulation
0 Comment
